Not an actual patient.
Frequently asked
questions (FAQs)
Expand the boxes below to learn about HYMPAVZI
HYMPAVZI is the first once-weekly, subcutaneous prophylactic treatment for adults and children 6+ with hemophilia A or B, with or without inhibitors that comes in a fixed-dose* prefilled pen.
*For children ages 6 to less than 12, the first dose (loading dose) is 150 mg on day 1, then a weekly (maintenance) dose of 75 mg as prescribed by your healthcare provider. For adults and adolescents 12+, the first dose (loading dose) is 300 mg on day 1, then a weekly (maintenance) dose of 150 mg as prescribed by your healthcare provider. If more than 1 injection is required to deliver a complete dose, administer each injection at a different site.1
HYMPAVZI is indicated for routine prophylaxis in adults and children 6 years and older with hemophilia A or B, with or without inhibitors. The BASIS study included 51 people ages 12 and older with hemophilia A or B with inhibitors, and the BASIS KIDS study included 34 children 6 to less than 12 years of age with hemophilia A or B with inhibitors. Talk to your healthcare provider to determine whether HYMPAVZI is an appropriate option based on your individual treatment needs.
HYMPAVZI is indicated for routine prophylaxis in adults and children 6 years and older with hemophilia A or B, with or without inhibitors, and has been studied in children 6 to <18 in the BASIS KIDS study. Talk to your healthcare provider about whether HYMPAVZI may be right for you or a child under your care.
You should use HYMPAVZI once a week, any time of day, on the same day each week.
Read the full Instructions for Use for detailed administration information or watch the Instructions for Use video to learn more about how to inject.
Your healthcare provider will tell you which dose to take (or give to a child under your care).
For adults and adolescents 12+:
- Loading dose: 300 mg (two 150 mg injections)
- Maintenance dose: one once-weekly 150 mg injection
For people weighing 50 kg (110 lb) or more, your healthcare provider may change the maintenance dose to 300 mg weekly if the 150 mg maintenance dose is not enough to prevent bleeding events.
Your healthcare provider will determine which HYMPAVZI dose is right for you.
HYMPAVZI is a fixed-dose, prefilled pen available in 2 doses. The child's healthcare provider will determine which HYMPAVZI dose is right for the child under your care:
For adolescents 12+:
- Loading dose: 300 mg (two 150 mg injections)
- Maintenance dose: one once-weekly 150 mg injection
For people weighing 50 kg (110 lb) or more, their healthcare provider may change the maintenance dose to 300 mg weekly if the 150 mg maintenance dose is not enough to prevent bleeding events.
For children 6 to less than 12:
- Loading dose: 150 mg (one 150 mg injection or two 75 mg injections)
- Maintenance dose: one once-weekly 75 mg injection
For people weighing 25 kg (55 lb) or more, their healthcare provider may change the maintenance dose to 150 mg weekly if the 75 mg maintenance dose is not enough to prevent bleeding events.
If you miss a maintenance dose of 75 mg of HYMPAVZI:
- Give the dose as soon as possible before the next scheduled dose, and then continue with your usual 75 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider
- If more than 13 days have passed since your last dose was given, you will need to restart with a loading dose. Call your healthcare provider right away for dosing instructions
If you miss a maintenance dose of 150 mg of HYMPAVZI:
- Give the dose as soon as possible before the day of your next scheduled dose, and then continue with your usual weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider
- If more than 13 days have passed since your last dose was given, you will need to restart with a loading dose. Call your healthcare provider right away for dosing instructions
If you miss 1 or more maintenance doses of 300 mg of HYMPAVZI:
- Give a dose as soon as possible, and then continue with your usual weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose
In case you are not sure when to inject HYMPAVZI, call your healthcare provider.
To help you stay on top of your treatment with HYMPAVZI, you can:
- Download the HemMobile® app
- HemMobile® is designed to help hemophilia patients with dosing reminders, recording bleeds, and tracking activity
- HemMobile® is free and available to download from the Apple App Store and Google Play
- Ask your healthcare provider about receiving a starter kit, which includes an injection tracker and other helpful tools and information to help you get started on HYMPAVZI
- Set a reminder on your phone calendar
- Record where you inject to make sure you change your injection site after every injection
- Take your injection on the same day each week. Pick a weekly activity, like doing laundry, and do it then
Apple is a trademark of Apple Inc., registered in the US and other countries. Google is a trademark of Google LLC.
Emergencies happen, but you can stay prepared. You may want to carry a medication card in your wallet and update your emergency information in your phone. If you are a caregiver, make sure the child under your care also carries their medication card with them, and if they have a phone, make sure they update emergency information on their phone.
If you or the child have a planned surgery, your healthcare provider may stop treatment with HYMPAVZI before your surgery. Talk to your healthcare provider about when to stop using HYMPAVZI and when to start it again if you have a planned surgery.
Do not use HYMPAVZI to treat breakthrough bleeding.
Your healthcare provider will provide information on the treatment of breakthrough bleeding during your treatment with HYMPAVZI.
Before you start using HYMPAVZI, it is very important to talk to your healthcare provider about using factor VIII and factor IX products or bypassing agents (products that help blood clot but work in a different way than HYMPAVZI).
Your healthcare provider may prescribe factor VIII, factor IX medicines, or bypassing agents to treat episodes of breakthrough bleeding during your treatment with HYMPAVZI. Carefully follow your healthcare provider’s instructions regarding when to use factor VIII or factor IX medicines and the prescribed dose during your treatment with HYMPAVZI. Do not use additional doses of HYMPAVZI to treat breakthrough bleeds.
Your healthcare team is your primary source for guidance and can provide information based on your or the child’s individual needs.
A range of support and resources is available to help you navigate treatment, including educational materials, information about financial support, and community support. Additional support may also be available through Pfizer Hemophilia Connect.